147 related articles for article (PubMed ID: 35269224)
1. A Visual Discrimination of Existing States of Virus Capsid Protein by a Giant Molybdate Cluster.
Xue Y; Wei M; Fu D; Wu Y; Sun B; Yu X; Wu L
Nanomaterials (Basel); 2022 Feb; 12(5):. PubMed ID: 35269224
[TBL] [Abstract][Full Text] [Related]
2. A hybrid HPV capsid protein L1 with giant Mo-containing polyoxometalate improves the stability of virus-like particles and the anti-tumor effect of [Mo
Xue YR; Wang Y; Chen G; Sun B; Li B; Wu L; Wu Y
Biomater Sci; 2021 May; 9(10):3875-3883. PubMed ID: 33890954
[TBL] [Abstract][Full Text] [Related]
3. Hybrid Assembly toward Enhanced Thermal Stability of Virus-like Particles and Antibacterial Activity of Polyoxometalates.
Fu DY; Zhang S; Qu Z; Yu X; Wu Y; Wu L
ACS Appl Mater Interfaces; 2018 Feb; 10(7):6137-6145. PubMed ID: 29381053
[TBL] [Abstract][Full Text] [Related]
4. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
Baek JO; Seo JW; Kim IH; Kim CH
Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
[TBL] [Abstract][Full Text] [Related]
5. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
6. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine.
Deschuyteneer M; Elouahabi A; Plainchamp D; Plisnier M; Soete D; Corazza Y; Lockman L; Giannini S; Deschamps M
Hum Vaccin; 2010 May; 6(5):407-19. PubMed ID: 20953154
[TBL] [Abstract][Full Text] [Related]
7. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
8. Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly.
Li M; Cripe TP; Estes PA; Lyon MK; Rose RC; Garcea RL
J Virol; 1997 Apr; 71(4):2988-95. PubMed ID: 9060658
[TBL] [Abstract][Full Text] [Related]
9. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.
El Mehdaoui S; Touzé A; Laurent S; Sizaret PY; Rasschaert D; Coursaget P
J Virol; 2000 Nov; 74(22):10332-40. PubMed ID: 11044077
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of human papillomavirus type 16 major capsid protein L1: the cysteines affecting the intermolecular bonding and structure of L1-capsids.
Ishii Y; Tanaka K; Kanda T
Virology; 2003 Mar; 308(1):128-36. PubMed ID: 12706096
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells.
White LJ; Hardy ME; Estes MK
J Virol; 1997 Oct; 71(10):8066-72. PubMed ID: 9311906
[TBL] [Abstract][Full Text] [Related]
13. A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2.
Tumban E; Peabody J; Peabody DS; Chackerian B
PLoS One; 2011; 6(8):e23310. PubMed ID: 21858066
[TBL] [Abstract][Full Text] [Related]
14. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies.
Christensen ND; Höpfl R; DiAngelo SL; Cladel NM; Patrick SD; Welsh PA; Budgeon LR; Reed CA; Kreider JW
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2271-6. PubMed ID: 7521393
[TBL] [Abstract][Full Text] [Related]
15. Encapsidating artificial human papillomavirus-16 mE7 protein in human papillomavirus-6b L1/L2 virus like particles.
Xu YF; Wang QY; Zhang HT; Han YH; Song GX; Xu XM
Chin Med J (Engl); 2007 Mar; 120(6):503-8. PubMed ID: 17439745
[TBL] [Abstract][Full Text] [Related]
16. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
17. A Novel Human Papillomavirus 16 L1 Pentamer-Loaded Hybrid Particles Vaccine System: Influence of Size on Immune Responses.
Jia C; Yang T; Liu Y; Zhu A; Yin F; Wang Y; Xu L; Wang Y; Yan M; Cai Q; Liang X; Ju R; Chen J; Wang L
ACS Appl Mater Interfaces; 2018 Oct; 10(42):35745-35759. PubMed ID: 30360122
[TBL] [Abstract][Full Text] [Related]
18. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris.
Sanchooli A; Aghaiypour K; Kiasari BA; Samarbaf-Zadeh A; Ghadiri A; Makvandi M
Protein Pept Lett; 2018; 25(8):783-790. PubMed ID: 30091403
[TBL] [Abstract][Full Text] [Related]
19. Cloning and Expression of L1 Protein Human Papillomavirus Type 31 Isolated from Iranian Patients in Escherichia coli.
Hajmohammadi S; Rassi H
Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):181-5. PubMed ID: 27244269
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes.
Thönes N; Müller M
Virology; 2007 Dec; 369(2):375-88. PubMed ID: 17822733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
